Hot Revenue Cycle Compliance Topics Stephen Gillis, Dir Compliance Coding Billing & Audit, Partners HealthCare Daniel Esquibel, Senior Manager, Deloitte & Touche LLP

• Provides an overview of price transparency rules for hospitals, including definition of standard charges and requirements for machine-readable and customer-friendly files
• Highlights strategic considerations for health systems of the Transparency in Coverage rule for payers, including employers offering self-funded coverage
• Addresses interaction of price transparency regulatory initiative with other federal rulemaking activities
• Identify new billing compliance risk areas that should be evaluated based on industry changes and recent OIG and other government agency reports
• Discuss methods for evaluating and monitoring new billing compliance risk areas

Break

Covid-19 Compliance Panel Discussion Session I; Patient and Employee Privacy Beth Gutoff, Chief Compliance & Privacy Officer, Elliot Health System Rick King, UMMMC Chief Compliance Officer, UMass Memorial Medical Center Todd Torres, Associate General Counsel , UMass Memorial Health Care

• This interactive panel discussion is the first of two sessions in which compliance professionals will share their experiences as it relates to the Covid-19 pandemic. This session will focus on the impact that Covid-19 had on both patient and employee privacy. The following are some key topics that will be discussed:
• Patient Privacy Considerations
• Employee Privacy Considerations
• Telehealth Privacy Considerations
• Submit your questions prior to the conference and the panel will include your question in the panel discussion. Live questions may also be submitted during the session.

Break

Covid-19 Compliance Panel Discussion Session II James Bryant, Chief Compliance Officer, Brigham & Women's Hospital Compliance Dept Beth Gutoff, Chief Compliance & Privacy Officer, Elliot Health System Rick King, UMMMC Chief Compliance Officer, UMass Memorial Medical Center Lawrence Vernaglia, Partner, Foley & Lardner LLP

• This interactive panel discussion is the second of two sessions in which compliance professionals will share their experiences as it relates to the Covid-19 from the perspectives of an Academic Medical Center, a Community Healthcare System, and a Healthcare Attorney. The session will focus on the following areas:
• Key compliance risks, e.g. Telehealth, EMTALA, Alternate Care Sites, Federal and State grants
• Impacts to compliance programs, e.g. changing roles and responsibilities, staffing and budget reductions, compliance policies and workplans
• Post pandemic planning, e.g. pandemic-specific workplan
• Submit your questions prior to the conference and the panel will include your question in the panel discussion. Live questions may also be submitted during the session.

Lunch Break

Keeping it Fresh: Strategies for Individual Development for Compliance and Privacy Professionals Danielle Fagan, Clinical Partner, Lifespan Donna Schneider, Vice President, Corporate Compliance and Internal Audit, Lifespan We all feel the effects of being “too busy” and finding time to invest in our own development is often a challenge. At the same time, the landscape of our work is ever changing, requiring us to stay current.

• Strategies for successful professional development for Compliance & Privacy staff, with a focus on leading self
• Participants will be inspired to increase their investment in their personal talent development and thrive in the workforce
• We will explore the importance and impact of individual growth, self-management, and staying current while on your Compliance & Privacy career journey

Break

Government Enforcement Panel Gregg Shapiro Amanda Strachan, Chief, Health Care Fraud Unit, United States Attorney's Office Michael Fee, Partner, Health Care & Life Sciences Group Verrill Dana LLP

• Discussion of DOJ Criminal and Civil Enforcement Priorities
• Emerging criminal and civil enforcement trends
• Recent cases, settlement agreements, CIAs, and related issues
• The role of data in criminal and civil healthcare fraud cases

Break

Reading the Tea Leaves: Projecting Change in the Healthcare Industry Relating to the 2020 Presidential Election Michael Capuano, Director, Public Affairs, Foley & Lardner LLP Michael Crossen, Partner, Foley & Lardner LLP

• Key health policy issues on the platforms of each candidate
• Predictions for what changes hospitals and other providers could expect following January 2021 inauguration
• What should a compliance officer be thinking about for projecting out the next 18 months